{"doi":"10.4149/neo_2014_030","title":"Individual-level data on the relationships of progression-free survival, post-progression survival, and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancer","abstract":null,"journal":"Neoplasma","year":2014,"id":18644,"datarank":1.0199954007971646,"base_score":3.4011973816621555,"endowment":3.4011973816621555,"self_citation_contribution":0.5101796072493234,"citation_network_contribution":0.509815793547841,"self_endowment_contribution":0.5101796072493234,"citer_contribution":0.509815793547841,"corpus_percentile":null,"corpus_rank":null,"citation_count":29,"citer_count":9,"citers_with_citation_signal":8,"citers_with_endowment":8,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":128840,"name":"T. Takahashi","orcid":null,"position":1,"is_corresponding":false},{"id":118595,"name":"K. Mori","orcid":null,"position":2,"is_corresponding":false},{"id":128841,"name":"A. Ono","orcid":null,"position":3,"is_corresponding":false},{"id":128842,"name":"H. Akamatsu","orcid":null,"position":4,"is_corresponding":false},{"id":128843,"name":"T. Shukuya","orcid":null,"position":5,"is_corresponding":false},{"id":128844,"name":"T. Taira","orcid":null,"position":6,"is_corresponding":false},{"id":128845,"name":"H. Kenmotsu","orcid":null,"position":7,"is_corresponding":false},{"id":128846,"name":"T. Naito","orcid":null,"position":8,"is_corresponding":false},{"id":128847,"name":"H. Murakami","orcid":null,"position":9,"is_corresponding":false},{"id":128848,"name":"M. Endo","orcid":null,"position":10,"is_corresponding":false},{"id":128849,"name":"T. Nakajima","orcid":null,"position":11,"is_corresponding":false},{"id":120004,"name":"N. Yamamoto","orcid":null,"position":12,"is_corresponding":false},{"id":128839,"name":"H. Imai","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.4011973816621555,"endowment":3.4011973816621555,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24299320","pmcid":null,"openalex_id":"https://openalex.org/W1986002373","authors":[],"funders":[],"total_grants":0,"fwci":1.6196,"citation_percentile":0.83901051,"influential_citations":2,"citation_trend":[{"year":2014,"count":2},{"year":2015,"count":3},{"year":2016,"count":2},{"year":2017,"count":4},{"year":2018,"count":4},{"year":2019,"count":1},{"year":2020,"count":3},{"year":2021,"count":4},{"year":2022,"count":4},{"year":2024,"count":1},{"year":2025,"count":1}],"oa_status":"bronze","license":null,"oa_locations":[{"url":"http://www.elis.sk/download_file.php?product_id=3674&session_id=7ogh9b9sad40o945ff3p0395o4","host_type":"journal"},{"url":"http://www.elis.sk/download_file.php?product_id=3674&session_id=7ogh9b9sad40o945ff3p0395o4","host_type":"BRONZE"},{"url":"http://www.elis.sk/download_file.php?product_id=3674&session_id=7ogh9b9sad40o945ff3p0395o4","host_type":"publisher"},{"url":"https://doi.org/10.4149/neo_2014_030","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/24299320","host_type":"repository"}],"fields_of_study":["Lung Cancer Treatments and Mutations","Lung Cancer Diagnosis and Treatment","Cancer Genomics and Diagnostics","Medicine","Biology","Adult","Aged","Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Cisplatin","Disease Progression","Disease-Free Survival","Female","Humans","Kaplan-Meier Estimate","Lung Neoplasms","Male","Middle Aged","Neoplasm Staging"],"mesh_terms":["Adult","Aged","Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Cisplatin","Female","Humans","Lung Neoplasms","Male","Middle Aged","Neoplasm Staging","Disease Progression","Disease-Free Survival","Kaplan-Meier Estimate"],"keywords":["Pemetrexed","Oncology","Medicine","Internal medicine","Lung cancer","Chemotherapy","Progression-free survival","Cisplatin","Surrogate endpoint","Tumor progression","Cancer","Survival analysis","Non-small Cell Lung Cancer, Overall Survival, Post-progression Survival, Progression-free Survival, Tumor Response"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-03T22:59:00.392653Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}